TITLE (("SGLT-2 inhibitor*" OR "sodium-glucose cotransporter 2 inhibitor*" OR "dapagliflozin" OR "empagliflozin" OR "canagliflozin" OR "ertugliflozin" OR "ipragliflozin" OR "luseogliflozin") AND ("heart failure" OR "cardiac failure" OR "congestive heart failure" OR "CHF" OR "left ventricular dysfunction")) AND (LIMIT-TO (DOCTYPE, “re”)). Here, SLC5A2 is linked to congestive heart failure.